From financialisation to innovation in UK Big Pharma : AstraZeneca and GlaxoSmithKline
Year of publication: |
2022
|
---|---|
Authors: | Tulum, Öner ; Andreoni, Antonio ; Lazonick, William |
Publisher: |
Cambridge : Cambridge University Press |
Subject: | financialisation | innovation | GlaxoSmithKline | AstraZenec | Innovation | Pharmaindustrie | Pharmaceutical industry | Finanzkapitalismus | Financial capitalism |
Extent: | 1 online resource (104 pages) digital, PDF file(s). |
---|---|
Series: | |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Title from publisher's bibliographic system (viewed on 30 Nov 2022) |
ISBN: | 978-1-009-27814-0 ; 978-1-009-27816-4 ; 978-1-009-27816-4 |
Other identifiers: | 10.1017/9781009278140 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Restructuring and innovation in pharmaceuticals and biotechs : the impact of financialisation
Gleadle, Pauline, (2014)
-
Kädtler, Jürgen, (2009)
-
Finanzmarktkapitalismus? : Der Einfluss von Finanzialisierung auf Arbeit, Wachstum und Innovation
Faust, Michael, (2017)
- More ...
-
US biopharmaceutical finance and the sustainability of the biotech business model
Lazonick, William, (2011)
-
Apple’s Changing Business Model: What Should the World’s Richest Company Do with All Those Profits?
Lazonick, William, (2013)
-
US Biopharmaceutical Finance and the Sustainability of the Biotech Boom
Lazonick, William, (2010)
- More ...